Design of expression vectors in transgenic animals, Biology

Design of expression vectors

Expressing a transgene in an appropriate manner is a huge task. The gene construct that is quite active in transfected cells may be only weakly expressed in transgenic animals. Moreover, each line of animals shows a specific pattern of transgene expression. In addition, a number of transgenes remain silent in some cells but are expressed in others. This is a clear limitation for the use of transgenic animals. A large number of transgenic founders are attempted until they find the lines expressing the foreign gene as they expected. This approach implies wastage of time and animals but it appears sufficient to obtain 1,000-10,000 copies of recombinant protein per cell exhibiting the expected biological action. This relative but real success of the expression vectors dissuaded researchers for years from improving them.

The situation is altogether different when recombinant proteins are to be prepared in milk. Highly efficient expression vectors are often needed to obtain the expected large amounts of proteins recovery from milk. However, it must be ensured that the recombinant proteins are restricted to milk as much as possible to avoid any potential deleterious effects on host animals. A significant amount of work was done for the production of recombinant proteins in milk and a few efficient expression vectors were designed and patented. Yet basic studies on the mechanisms of gene expression and empirical observations have led to defined rules for vector con­struction and to identification of pitfalls that can be avoided. A functional transcription unit is composed of several elements that cooperate with each other. These elements and their mode of action are not yet fully known. A gene construction consists of associating more or less known elements. This may generate nonfunctional vectors for unknown reasons. The major recommendations for design­ing reliable vectors may be summarized as follows.

Posted Date: 9/18/2012 7:42:23 AM | Location : United States







Related Discussions:- Design of expression vectors in transgenic animals, Assignment Help, Ask Question on Design of expression vectors in transgenic animals, Get Answer, Expert's Help, Design of expression vectors in transgenic animals Discussions

Write discussion on Design of expression vectors in transgenic animals
Your posts are moderated
Related Questions
Q. What is the evolutionary advantage of the occurrence of larval stage and sperm cells in the life cycle of sponges? The sexual reproduction in sponges in addition to contribu

Biogeochemical Cycling - Nutrient Cycles The energy flows through ecosystems enabling the organisms to perform various kinds of work, and is ultimately lost as heat. It is gon

A calico female has a litter of kitten which includes several calico females a yellow male a couple of yellow females and two black males what is the likely color of the father and

What is Mendel's second law? Mendel's second law postulates that two or more different traits are also conditioned by two or more pair of dissimilar factors and that each inhe

Explain Gene Expression - Nutrient Gene Interactions? The last two decades have witnessed tremendous development in our understanding of the cellular processes at the molecular

Q. Physiological Characteristics of molds? The physiological characteristics of molds will be reviewed only briefly here and will be discussed in more detail subsequently. Mois

What is the main moral problem about the cloning of human individuals? Besides biological perils, a very serious moral problem includes the nucleus transplantation technology c

Explain the Carbohydrate required for underweight - Nutritional Care? Liberal amounts of easy to digest carbohydrates should be included in the diet. The intake of dietary fibr

Define Vigorous or vigorously active lifestyles - physical activity? These people engage regularly in strenuous work or in strenuous leisure activities for several hours. Examp

Explain Fomivirsen  Fomivirsen, an  antisense oligonu- cleotide, is FDA-approved for intravitreal treatment of CMV retinitis in HIV-infected patients who cannot tolerate or ha